Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Krystal Biotech, Inc. (KRYS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
3
| Mazzacco Catherine (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 01/26/2022 |
3
| Sutherland Everett Rand (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 05/11/2021 |
3
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 3 on Krystal Biotech, Inc. |
| 01/05/2021 |
3
| Marantz Jing L. (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 01/05/2021 |
3
| Mason Christopher (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 02/25/2020 |
3
| Romano Kathryn (Chief Accounting Officer) has filed a Form 3 on Krystal Biotech, Inc. |
| 01/31/2020 |
3
| Chien Jennifer (Chief Commercial Officer) has filed a Form 3 on Krystal Biotech, Inc. |
| 03/06/2019 |
3
| Gangolli Julian S (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 05/24/2018 |
3
| Riley Antony A (CFO) has filed a Form 3 on Krystal Biotech, Inc. |
| 09/19/2017 |
3
| Sun Pharma (Netherlands) B.V. (10% Owner) has filed a Form 3 on Krystal Biotech, Inc. |
| 09/19/2017 |
3
| Ganorkar Kirti (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|